ReviewBrain : a journal of neurology2026
Routes of precursors' migration in remyelination.
Review in Brain : a journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Angiotensin II impairs the remyelination mediated by brain endothelial cell-derived exosomes.Acta neuropathologica communications · 2026Article
- Endothelial-specific Ezh2 deficiency exacerbates blood-brain barrier dysfunction and neuroinflammation in sepsis-associated encephalopathy.Journal of neuroinflammation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Remyelination, the biological process of restoring myelin sheaths, is critically dependent on the successful recruitment of oligodendrocyte lineage cells. However, this process involves at least two functionally distinct endogenous reservoirs: the widely distributed parenchymal oligodendrocyte precursor cells (pOPCs) and neural stem cells (NSCs) originating from the subventricular zone (SVZ). Emerging evidence reveals that these populations employ different migratory strategies. The pOPC response is characterized by rapid local proliferation but severely constrained, short-range migration, often limited by an inhibitory lesion microenvironment. In contrast, SVZ-derived precursors, including fate-switching neuroblasts, are capable of long-range, adaptive migrations, navigating complex routes by co-opting both vascular and parenchymal scaffolds. This review synthesizes these divergent phenomena into a unifying model of competing migratory programmes. We posit that the success or failure of endogenous repair depends on a dynamic interplay between the limited local pOPC response and the recruitment of the more plastic, long-range SVZ-derived cohort. We examine how the oligovascular niche and pivotal signalling cascades, including Wingless/Int-1-β-catenin (Wnt/β-catenin), bone morphogenetic protein (BMP), and sonic hedgehog/glioma-associated oncogene (Shh/Gli), function as critical regulators in this process, dictating which migratory strategy predominates in a given pathological context. Viewing remyelination as a dynamic balance between these two cellular systems helps explain why this repair process often fails. Ultimately, understanding these migratory programmes as an interconnected system, rather than as isolated components, is essential for developing more effective interventions that promote functional myelin repair in demyelinating diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.